Proteolytic Fragments of Anti-HIV and Anti-tumor Proteins MAP30 and GAP31 Are Biologically Active
Open Access
- 1 September 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 262 (3) , 615-623
- https://doi.org/10.1006/bbrc.1999.1213
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lysozyme and RNases as anti-HIV components in β-core preparations of human chorionic gonadotropinProceedings of the National Academy of Sciences, 1999
- Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.Proceedings of the National Academy of Sciences, 1995
- Crystallization and Preliminary X-ray Analysis of GAP 31: A protein Which Inhibits the Life Cycle of HIV-1Journal of Molecular Biology, 1994
- Crystal structure of momordin, a type I Ribosome Inactivating Protein from the seeds of Momordica charantiaFEBS Letters, 1994
- Structure of recombinant ricin A chain at 2.3 ÅProtein Science, 1993
- A new class of anti‐HIV agents: GAP31, DAPs 30 and 32FEBS Letters, 1991
- Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in CultureCancer Communications, 1991
- MAP 30: a new inhibitor of HIV‐1 infection and replicationFEBS Letters, 1990
- DNA Polymerases α and δ Are Immunologically and Structurally DistinctPublished by Elsevier ,1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970